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Learning curves in health are of interest for a wide range of medical disciplines,
healthcare providers and policy makers. In this paper, we distinguish between
three types of learning when identifying overall learning curves: economies of scale,
learning from cumulative experience and human capital depreciation. In addition,
we approach the question of how treating more patients with specific characteris-
tics predicts provider performance. To soften collinearity problems, we explore the
use of Lasso regression as a variable selection method and Theil-Goldberger mixed
estimation to augment the available information. We use data from the Belgian
Transcatheter Aorta Valve Implantation (TAVI) registry, containing information
on the first 860 TAVI procedures in Belgium. We find that treating an additional
TAVI patient is associated with an increase in the probability of 2-year survival by
about 0.16%-points. For adverse events like renal failure and stroke, we find that an
extra day between procedures is associated with an increase in the probability for
these events by 0.12%-points and 0.07%-points respectively. Furthermore, we find
evidence for positive learning effects from physicians’ experience with defibrillation,
treating patients with hypertension and the use of certain types of replacement
valves during the TAVI procedure.
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1 Introduction
The idea of a link between the volume of treated patients and healthcare provider per-
formance is well-known, but uncertainty remains about the source of this relationship.
In this respect, the issue of learning by doing or cumulative learning is most frequently
encountered in empirical research. Economic research additionally considers economies
of scale, human capital depreciation, reverse causality, level of specialization and social
learning or “learning by watching” as factors explaining volume-outcome relationships
(Ho, 2002; Gaynor et al., 2005; Huesch, 2009; Hockenberry and Helmchen, 2014; Lee
et al., 2015; Mesman et al., 2015). Data collinearities however hamper inference so that
theoretical arguments lead most studies to include only a subset of these effects. In this
paper, we analyze multiple factors simultaneously and we emphasize the potential role
of patient subgroups in the learning process. Common policies are volume thresholds for
hospitals, report cards and team/provider training (Huesch and Sakakibara, 2009). The
approach followed in this paper provides more information on where improvements may
be made by healthcare providers and this might improve the quality of team and provider
training.
In this paper, we identify three types of learning: economies of scale, cumulative ex-
perience and human capital depreciation. Economies of scale refer to total volume effects
captured by annual hospital patient volumes. The rationale here is that hospitals with
more patients are likely to be better equipped and to have more standardized procedures
potentially mapping into better provider performance. Economies of scale have been
found to be important for both CABG (coronary artery bypass graft) and PTCA (per-
cutaneous transluminal coronary angioplasty) in the literature (Ho, 2002; Gaynor et al.,
2005). Cumulative experience1 refers to the number of patients that have been treated in
the past capturing classical learning by doing effects. Finally, human capital depreciation
evaluates the role of time since the last procedure. For CABG and PTCA, cumulative
learning has been found to only play a minor role (Ho, 2002; Gaynor et al., 2005). In
1In what follows, we use the terms “cumulative experience” and “cumulative learning” interchangeably.
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contrast, human capital depreciation seems to be important for CABG (Hockenberry and
Helmchen, 2014).
In line with the existing literature, we disentangle these overall learning effects in a
first step. Subsequently, we follow a data-driven approach to detect learning mechanisms
in patient subgroups. Given that performance is predicted by economies of scale, cu-
mulative experience and/or human capital depreciation, these effects may well be driven
by particular patient subgroups. More specifically, we assess how treating more patients
with certain subgroup characteristics predicts overall health outcomes. Quantifying such
information goes beyond the typical volume-outcome relationship and potentially imparts
new insights on how to improve health outcomes for new, under-performing or lower vol-
ume providers and possibly allows to better identify the sources of learning. For typical
outcomes like in-hospital mortality, physicians may have a general feeling on how to im-
prove performance. This is however much less the case for other outcomes like long-term
mortality or procedural characteristics.
Existing studies mostly explore patient subgroups from a different point of view,
namely how overall volumes influence specific patient subgroups. In contrast to that,
in this paper we asses how overall learning effects can be attributed to certain subgroups
and therefore providing information for policy makers on how to concentrate procedures
in hospitals. An example related to subpopulation effects in trauma care is Matsushima
et al. (2014), where larger volumes of geriatric patients were associated with lower mor-
tality and complications among geriatric patients. Larger non-geriatric volumes on the
other hand were associated with higher odds of major complications. In Pasquale et al.
(2001), higher- (overall) volume centers were more successful in treating patients in seven
out of nine injury types (Caputo et al., 2014).
Our data covers all patients in Belgium that underwent a transcatether aorta valve
implantation (TAVI) between 2007 and 20122. For TAVI, experience has been shown to
have an impact on mortality (30-day and 1-year), the duration of procedures, contrast
2The very first patient underwent TAVI in Belgium in 2007.
3
volumes and radiation (Möllmann et al., 2015; Alli et al., 2012; Kempfert et al., 2012). Al-
though these findings are based on descriptive analysis, they provide suggestive evidence.
In this study, we go beyond simple univariate/descriptive analysis as we isolate the learn-
ing effects at hand by controlling for a broad range of patient- and procedure-specific
characteristics, as well as hospital fixed-effects3.
Overall we find that different learning processes apply for different health-related out-
comes: While cumulative experience significantly predicts 24-month survival, human cap-
ital depreciation has a significant effect on several Major Adverse Cardiac and Cere-
brovascular Events (MACE). These events occur as a result of procedural complications.
In particular, our results suggest an increase in 24-month survival of 0.16%-points for
every extra TAVI patient treated. Furthermore, the likelihood of having a renal failure
or a cerebrovascular stroke is increased by 0.12%-points and 0.07%-points respectively for
every additional day since the last TAVI procedure.
While multicollinearity is an issue when estimating overall learning curves, it is even
more problematic in the estimation of subgroup effects. By treating more patients overall,
by definition, also more patients are treated within specific subgroups. Therefore, an
important contribution of this paper to the learning curves literature is that we propose
two methodological approaches on how to disentangle these (subgroup) learning effects.
Firstly, we single out relevant predictors for two-year mortality using Lasso regression
(Tibshirani, 1996). Secondly, in a Bayesian spirit, we apply Theil-Goldberger mixed
estimation to add objective information to the model to soften multicollinearity problems
(Theil and Goldberger, 1961). Theil-Goldberger estimation allows the inclusion of prior
information on a sum of coefficients which improves the information to identify subgroup
learning effects. Subgroup learning effects for 24-month survival are found for patients
with aortic aneurysm, atrial fibrillation, carotis disease, hypertension, porcelain aorta,
NYHA category three and transfemoral access. That is, treating more patients with
3We do not claim causality regarding our estimated learning effects as the data does not allow us to
completely rule out reverse causality and potential patient or provider self-selection.
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these characteristics positively or negatively influences 24-month survival. These effects
may be attributed to improved knowledge, knowledge transfer or to selection effects in
these subgroups.
The remainder of the paper is organized as follows: In section 2, we discuss the data
at hand (the Belgian TAVI registry) and the variables used in the analysis. In section 3,
we discuss the identification strategy and substantive questions of the paper. In section
4, we present our main results for the overall and subgroup learning effects. Section 5
continues with robustness checks before we draw final conclusions in section 6.
2 Data
This study uses the Belgian TAVI registry which contains detailed information on the
first 860 patients undergoing TAVI in Belgium in 23 different centers between 2007 and
2012. The data has been collected at the participating centers and has been approved by
the institutional ethics committees. The registry holds a wide range of control variables
on patient- and procedure-specific characteristics, as well as hospital identifiers. In each
hospital, the TAVI procedure is only executed by one specialized team, but we do not have
information on physician or hospital characteristics4. Whereas the workload with respect
to TAVI steadily increased over time, the workload of TAVI during our sample period
was relatively limited. We have detailed information on the demographic background of
patients, comorbidities, indicators for the severity of the cardiac problem and procedural
characteristics (see section 3.1 for more details). The patient outcomes we study are 24-
month survival, as well as indicators for major adverse cardiac events (MACE) including
renal failure, pacemaker implantation and stroke. Renal failure is known to be related to
the use of contrast volumes during the TAVI procedure. Furthermore, stroke and pace-
maker implantation are both typical complications in cardiac procedures and surgeries.
Pacemaker implantation is known to be strongly related to the type of valve that is used.
4Physician and hospital characteristics have shown to be significant predictors of health outcomes (see
e.g. Ho (2002)) and would therefore ideally be included in the analysis to further address patient and
provider selection issues.
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Two brands of valves are used in Belgian hospitals: CoreValve and SAPIEN and each
Belgian hospital only uses one of the two brands. More detailed descriptive statistics are
shown in the appendix.
Figure 1 below shows a positive relationship between the number of TAVI patients
treated and 2-year survival providing first evidence for learning from cumulative experi-
ence (see top left graph). The raw data is overlaid with linear and quadratic prediction
plots (dashed and solid dark blue lines) and the gray areas show the 95% confidence inter-
vals for the quadratic fits. Note also that the quadratic and linear fits are nearly identical
pointing toward a linear relationship between 2-year survival and cumulative experience.
In addition, there is clearly a positive association between pacemaker implantations and
cumulative experience (top right graph). This suggests that as more patients are treated,
they are more likely to receive a pacemaker during the TAVI procedure. This finding is
most likely driven by the use of CoreValve valves in the larger centers because this type
of valve is known to be associated with pacemaker implantation. In contrast to that, the
rate of adverse events for stroke and renal failure is roughly constant across all experience
levels suggesting no volume-outcome relationship.
— Insert Figure 1 here —
In line with the findings of Hockenberry and Helmchen (2014), it is expected that the
probability of mortality or major adverse cardiac events increases with temporal distance
to the last procedure. Physicians’ skills may suffer from a spell without practice which
makes them more likely to make suboptimal decisions during procedures. We find evidence
for such negative effects of human capital depreciation for renal failure and stroke as
depicted in Figure 2 below. In both cases, we observe a slightly positive relationship
between the number of days since the last procedure and the likelihood of having a stroke
or suffering from renal failure (see bottom left and right graphs). As for 2-year survival
and pacemaker implantations the linear and quadratic fits diverge and thus the presence
6
of human capital depreciation effects is unclear in this context5.
— Insert Figure 2 here —
3 Methodology and substantive questions
In a first step, we focus on overall learning curves in long-term patient survival and
major adverse cardiac events (MACE) including renal failure, stroke and pacemaker im-
plantations. Subsequently, we broaden our scope to learning curves for specific patient
subgroups. This evokes two substantive questions: First, if more patients are treated over-
all, are specific subgroups heatlhier on average? Second, when treating more patients in
specific subgroups, do providers get better in their overall care provision? Unlike the ex-
isting literature [e.g. Matsushima et al. (2014)], this paper focuses on the second question
as it provides useful information to transfer knowledge between practitioners and possibly
imparts new knowledge on how to improve health outcomes for under-performing or lower
volume providers.
3.1 Overall Learning Curves
We estimate linear probability models (LPM) to identify overall learning effects. Fol-
lowing Huesch and Sakakibara (2009), we distinguish between three types of learning:
economies of scale (Huckman and Pisano, 2006; Gaynor et al., 2005; Ho, 2002), learning
from cumulative experience (Ho, 2002; Karamanoukian et al., 2000) and human capital
depreciation (Hockenberry and Helmchen, 2014; Ramanarayanan, 2008; Huckman and
Pisano, 2006). Using patient-level data, we estimate models of the following form:
Outcomei,h,t = β0 + β1Economies of Scaleh,t + β2Cumulative Experiencei,h,t






5See the appendixes A, B and C for more descriptive statistics of the data at hand.
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Our outcome variables are binary indicators for 24-month survival and MACE indica-
tors for pacemaker implantation, renal failure and stroke for patient i treated in hospital h
in year t. Economies of Scaleh,t measures the annual number of procedures in hospital h
in year t picking up static scale effects. The rationale here is that high-volume hospitals are
more likely to be better equipped and possibly have improved processes of care and more
standardized procedures (Gaynor et al., 2005; Ho, 2002). Cumulative Experiencei,h,t is
the patient number for individual i in hospital h in year t reflecting learning from cumula-
tive experience (Ho, 2002). This variable indicates if the treatment of additional patients
predicts provider performance. Human Capital Depreciationi,h,t is the amount of days
that have passed since the last TAVI procedure for patient i in hospital h and year t and
captures the above mentioned human capital depreciation effect. It is sensible that the
longer the time between procedures, the more skills suffer from the absence of practice
(Hockenberry and Helmchen, 2014).
Besides our three main volume and time indicators, we control for a vector of patient-
and procedure-specific characteristics Xi,h,t which includes information on the demo-
graphic background of a patient (age, gender), comorbidities (indicators for various heart
diseases, diabetes, renal failure, angina and existing pacemaker), the severity of the car-
diac problem (NYHA6 categories, ejection fraction, aortic valve area, peak and mean
gradient), as well as procedure-specific characteristics (type of valve and size of valve
implanted). We control for these observable characteristics as they have been identified
in the literature to be key determinants of mortality (Holt et al., 2007). Conditioning
on all these factors allows us therefore to isolate the different types of learning effects
outlined above. In addition, we include a vector of hospital fixed-effects Hh to account
for time-invariant unobserved factors such as quality of care and hospital management
quality that potentially differ across hospitals and affect the health-related outcomes of
interest. Finally, εi,h,t is a classical error term capturing all unobserved factors such as
genetic endowment and health behaviors of patients that also explain our outcomes of
6The New York Heart Association (NYHA) Classification is a frequently used measure to indicate the
severeness of cardiac disease and the extent of heart failure.
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interest besides the included explanatory variables.
Time fixed-effects can also be added to the empirical specification to capture “learning-
from-watching” and technological improvements. Similar to Ho (2002), adding year fixed-
effects likely results in highly collinear effects. Leaving out the time fixed-effects from
our models then necessitates interpretation of other learning effects as upper bounds on
the true effects because they may pick up part of the positive effect of technological
improvements over time.
3.2 Multicollinearity and Subgroup Learning Curves
In the subgroup analysis, all variables from the overall analysis are retained and experience
variables are introduced for all background characteristics. That is, if for example the
30th patient for a provider (hospital) is the 15th patient with hypertension for the same
provider, the patient gets patient number 30 (cumulative experience) and experience for
hypertension 15. Statistically these variables are likely to be strongly correlated7. By
treating more patients overall, also more patients with renal failure, porcelain aorta, etc.
will be treated.
To deal with multicollinearity, two general solutions are often proposed: Firstly, the
selection of a subset of variables remedies the consequences of multicollinearity by remov-
ing the collinearities. Therefore, we explore the use of the Least absolute shrinkage and
selection operator (Lasso) to obtain an optimal subset of experience variables predicting
our health-related outcomes of interest.
Secondly, increasing information provides more evidence to disentangle even collinear
effects. This extra information may come from an increase of the sample size or from
a restriction on regression coefficients. In this paper, we apply the Theil-Goldberger
mixed estimation method to introduce uncertain information on a sum of coefficients.
Although variable selection methods and the use of extra information have very different
7Correlations larger than 0.9 are no exception in our sample.
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motivations, they are both applications of constraints in a regression analysis. This is
discussed in more detail throughout the next sections.
3.2.1 The Least absolute shrinkage and selection operator (Lasso)
To select an optimal subset of regressors, multiple statistical approaches can be considered:
Subset selection techniques such as forward- and backward-stepwise selection, forward-
stagewise regression or shrinkage methods including Ridge regression and the Lasso. These
methods improve prediction accuracy and interpretation but come at the cost of biased
estimates (Hastie et al., 2009). Shrinkage methods are based on the idea of shrinking single
coefficients or sets of coefficients towards zero which trades off lower variance for increased
bias. Among all shrinkage methods, Lasso regression introduced by Tibshirani (1996), is
favored in this paper because it is more subtle compared to forward- and backward-
selection, while at the same time it provides sparser results compared to Ridge regression
and Elastic Net regression. Technically, the Lasso minimizes the residual sum of squares
subject to the constraint that the sum of all absolute values of coefficients is below some













|βj| ≤ t (2)
where the first part of equation 2 simply finds the β′s for which the sum of squared
residuals is lowest. The second part states that the minimization is subject to the condi-
tion that the sum of the absolute values of β should be lower than a constant t. Whereas
the approach is similar to Ridge regression where a similar constraint is placed on the sum
of all squared coefficients, the geometric properties of the Lasso set more coefficients ex-
actly equal to zero (Tibshirani, 1996). Additionally, because it is not a discrete process in
which variables are added one by one, the Lasso is less greedy than forward- or backward-
variable selection (Efron et al., 2004). Lasso estimates are obtained from the Least Angle
Regression Selection (LARS) algorithm in which the optimal set of coefficients is the one
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where Mallows’ Cp reaches a minimum.
The Lasso singles out the most significant variables that predict health outcomes. Next
to the standard Lasso, we also employ some modifications and extensions of the Lasso as a
robustness exercise. Firstly, we use the Lasso to select a subset of optimal predictors and
use them in standard OLS regressions. This approach is suggested in Efron et al. (2004);
Meinshausen (2007); Hastie et al. (2009) to reduce the bias and to allow for a simpler
interpretation of the coefficients. Secondly, we also restrict the Lasso by adding the “main
effects” first. Thirdly, we run logistic Lasso regressions as our outcomes of interest are
binary. Similarly to the Least Squares Lasso, an L1
8 penalty on the absolute values of
coefficients can be introduced to logistic regression (Genkin et al., 2007). Fourthly, we also
apply Elastic Net regression which is a hybrid between Lasso and Ridge regression and
uses weighted L1 and L2 penalties. The benefit of Elastic Net is that it copes better with
highly correlated regressors, i.e., among groups of highly correlated variables it singles
out multiple variables whereas the Lasso only includes one variable.
3.2.2 Including prior information with Theil-Goldberger mixed estimation
Multicollinearity can be interpreted as the occurrence of “undominated uncertain prior
information” (Leamer, 1973). This definition points out that including extra prior in-
formation might soften the multicollinearity problem. In this study, prior information
from within the data can be used to estimate subgroup effects. Intuitively it is clear
that the overall cumulative learning effect is the sum of all underlying subgroup effects.
Interesting in this regard is the Theil and Goldberger (1961) mixed estimation method
which uses GLS on an augmented dataset. In this augmented dataset, the data is supple-
mented by a dummy observation with information on the mean and variance of a (sum
of) coefficient(s).
The Theil-Goldberger coefficients and variances, where prior and data information are
8An L1 penalty is a constraint on the sum of absolute coefficient values as in equation (2). Alterna-
tively, an L2 penalty is a constraint on squared coefficient values used in Ridge regression.
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efficiently weighted in a GLS framework, are given by (Theil and Goldberger, 1961):
β̂ = [X ′Ω−1X +R′Ψ−1R]−1[X ′Ω−1y +R′Ψ−1r] (3)
and
V (γ̂) = [X ′Ω−1X +R′Ψ−1R]−1 (4)
X is a n × k matrix of observations on independent variables; Ω is the n × n variance-
covariance matrix of error terms and Ψ is the variance-covariance matrix of the prior
information. For prior information on a sum of coefficients, the 1 × k vector R and the
scalar r have to be specified. For example, imposing a constraint on the sum of β1 and
β2 could be achieved by specifying:
R = [1 1 0 · · · 0 0] (5)
r = [ ̂β1 + β2] (6)
As such, equations (3) and (4) are the result of applying GLS to the following two equa-
tions:
y = Xβ + u (7)
and
r = Rβ + v (8)
Equation (7) holds the relationship for the “real” data. Next, the real data is augmented
with an extra observation in the form of the constraint in equation (8). The main dif-
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ference with applying exact constraints is that there is some uncertainty about the prior
information (hence the Ψ matrix). To see how the internal information can be used here
as prior information, first consider a consistent (and linear) estimate of the learning curve:
sij = β0 + β1Cumulative Experienceij + β2Characteristic 1ij + εij (9)
sij stands for two-year survival for individual i in hospital j and Cumulative Experience is
the patient number of an individual (e.g. patient number 1 in hospital 20). In equation (9),
the coefficient on Cumulative Experience, β1, is consistently estimated using standard
regression techniques. Now let us think of a second model:
sij = γ0 + γ1Cumulative Experienceij + γ2Characteristic 1ij
+ γ3Exper Characteristic 1ij + εij
(10)
In this model Exper characteristic 1ij is a variable taking the value zero for the first
patients until there has been one person with a certain characteristic (say characteristic
1). From then onwards, the variable Exper characteristic 1ij takes on the value one and
is not increased until another patient with the same characteristic is treated. In equation
(9), β1 is a consistent estimate for the increase in the health outcome every time an extra
patient is treated in a hospital. In equation (10), the same increase in health outcome for
every extra patient is given by γ1 and γ3. That is, every time an extra patient is treated,
health increases by γ1 and also with approximately the amount γ3×avg(characteristic 1).
The increase with γ1 is obvious while the second part is an increase of γ3 for every
patient with characteristic one and on average only avg(characteristic 1) of the patient
population has the characteristic. As such on average, every time an extra patient is
treated, the outcome increases by γ3 × avg(characteristic 1). β1 in equation (9) can
therefore be seen as the sum of γ1 and γ3 × avg(characteristic 1). The translation of
this prior theoretical knowledge to the matrices that define the constraint on the sum of
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coefficients is as follows:
R = [1 avg(char1) 0 · · · 0 0] (11)
and
r = [β̂1] (12)
3.3 Endogeneity
In our context, endogeneity issues regarding the estimated learning effects may typically
arise because of (i) selective referral or (ii) reverse causality. In principle, more expe-
rienced providers might be able to select desirable patients with a higher likelihood of
survival and refer others to their colleagues thus creating a classical omitted variable bias
problem (patient selection). In addition, if overall health outcomes for different health
care providers are publicly known, then this might cause certain patients to select into
specific hospitals (provider selection). We cannot perfectly address these selection issues
in our analysis due to the lack of detailed physician and hospital characteristics ruling
out a causal interpretation of the estimated learning effects. However, by splitting up the
learning effect in subgroups, as illustrated in section 3.2, we capture part of the patient
selection (and selective referral effect) in the subgroup analyses. Subgroup experience
effects represent either a true learning effect or a selection effect regarding a specific sub-
group, e.g., over time patients with a less severe degree of a characteristic could be more
likely to be treated than others. In interpreting the results, it is important to stress that
both effects are interesting in their own right, but that they cannot be empirically disen-
tangled. Furthermore, because subgroup experiences are included, the overall cumulative
experience effect is measured more accurately because the selection in these subgroups is
no longer captured by the overall effect.
Regarding reverse causality, the existing literature provides mixed evidence on the di-
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rection of causation: Gaynor et al. (2005) and Ho (2002) find that causality mainly runs
from volume to outcome whereas Ramanarayanan (2008) finds that sicker patients may
select higher volume providers. In the Belgian setting, there is very little public informa-
tion on hospital quality, and even less on procedure related hospital quality. Moreover,
mortality rates across hospitals are only available to practitioners and are anonymized.
4 Results
4.1 Overall Learning Curves
We estimate the overall learning effects using linear probability models (LPM) for 24-
month survival, as well as several Major Adverse Cardiac Events (MACE) including pace-
maker implantation, renal failure and stroke. Model one shows the plain overall learning
effects for the three learning measures economies of scale, learning from cumulative ex-
perience and human capital depreciation; model two adds patient- and procedure-specific
characteristics as described above in section 3.1; finally, in model three we also include
hospital fixed-effects. In addition, we include a binary indicator for ”Zero Days Since Last
Procedure” in all model specifications because there are regularly two TAVI procedures
scheduled on one day. We also replicated our findings using probit/logit specifications to
relax the implicit linearity assumption in the marginal effects9
The estimated overall learning effects on survival can be found in table I below: First,
we find a positive and significant effect on the cumulative experience indicator for 24-
month survival pointing toward learning from doing across all three model specifications.
Specification (3) suggests that treating an additional TAVI patient is associated with an
increase in the probability of 2-year survival of about 0.16%-points, ceteris paribus. This
effect is sizeable considering that patient volumes were increased on average by more than
10 patients per year in the timespan from 2007 to 2012. The cumulative learning effect
9We refrain from showing the probit/logit estimates as the average marginal probability effects are
almost perfectly identical to the LPM estimates shown below.
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can be interpreted as the result of a learning process in technical skills, but also in the
selection process of patients by physicians. More experienced teams might be better in
selecting patients with a high probability of being alive after 2 years. Also, in the very
beginning of the procedure, providers might not yet be aware of the limited potential of
the procedure.
Second, table I also provides weak evidence for economies of scale as models one
and two show negative and significant coefficients on the annual patient volume mea-
sure. However, the effects is no longer significant when hospital fixed-effects are included
in specification three. The hospital fixed-effects pick up volume effects persisting over
time and therefore the yearly volume effects become insignificant when including hospi-
tal indicators. Third, our estimates do not indicate that human capital depreciation is
associated with survival as our time difference indicators do not show any statistically
significant coefficients.
— Insert Table I here —
In addition to the effects on patient survival, we also analyze adverse cardiac events.
The results are summarized in table I above. While cumulative learning showed to be
significant for survival, human capital depreciation is significant for several MACE. The
likelihood of suffering a renal failure or a stroke during the procedure is significantly
higher when more days have passed since the last TAVI procedure. The estimates suggest
that the likelihood of renal failure after TAVI is 0.12%-points higher for every additional
day since the last procedure. For stroke, an additional day since the last procedure is
associated with an increase in the probability of suffering a stroke of about 0.07%-points.
Again these skill depreciation effects can be considered sizeable as the average number
of days between procedures is more than 10 days across all hospitals and time periods.
Regarding stroke, we also find that patients treated on the same day (“Zero Days Since
Last Procedure”) have a higher probability of getting a stroke which may point out that
16
the team loses concentration during the course of a given day. As can be seen in the
robustness section, the results on MACE should be interpreted with care as the results
are sometimes driven by only a few extreme observations.
Summing up, we find that different types of learning apply for different outcomes:
Learning from cumulative experience is relevant for 24-month survival and more frequent
practice plays a key role for adverse events. Skills required for preventing these events
may depreciate over time as illustrated for renal failure and stroke.
4.2 Subgroup Learning Curves
Knowing that different types of learning apply for different outcomes, it is interesting to
investigate to what extent patient subgroups account for these overall learning effects.
Table II below shows the estimates of a linear probability model (LPM) using 24-month
survival as the dependent variable while controlling for all patient- and procedure-specific
characteristics, as well as hospital fixed-effects. In addition, the model also includes all
the experience variables for each of the background characteristics. Overall the results in-
dicate both positive and negative experience effects: For example, treating more patients
with diabetes is associated with an increase in 24-month survival, though statistically
insignificant. Positive effects may exist because of actual learning within specific sub-
groups or because of positive patient selection over time. On the other hand, treating
patients for example with an aortic aneurism has a significant negative effect on 2-year
survival indicating that this subgroup might be carefully examined to improve future
health improvements. Finding negative subgroup effects can be due to two facts: Firstly,
“experience” for a certain characteristic may be transferred from some subgroups to oth-
ers where it actually should not be transferred. Secondly, over time, “worse patients” with
stronger manifestations of the characteristic and thus per se lower probability of survival
may be treated.
The table also clearly shows the underlying multicollinearity issue in the regression
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when looking at column VIF which displays the Variance Inflation Factors10. Nearly all
experience variables have VIF values higher than ten, indicating strongly inflated standard
errors and rendering most subgroup learning effects statistically insignificant.
— Insert Table II here —
4.3 Lasso Regressions
The Lasso selects those variables most correlated to the dependent variable. Whereas it
succeeds in singling out the most relevant variables, it simultaneously ignores the fact that
the variables may typically pick up effects from other variables. In this sense, some of the
variables may in fact not be relevant, but only become statistically significant because of
their relationship with other characteristics. Nevertheless, singling out the most relevant
experience predictors might inform where to start looking to improve health outcomes.
Table III below contains a range of Lasso-related specifications: In the first specifica-
tion (1), we apply OLS on the Lasso selection of best predictors. This is done to reduce
the bias in the estimated parameters and to facilitate interpretation. Here the Lasso re-
veals that the overall annual TAVI volume and three subgroup experience variables are
particularly relevant for survival: First, treating more patients with a porcelain aorta11
is negatively associated with 24-month survival, though statistically insignificant. This
negative effect may be caused by irrelevant knowledge transfer between subgroups or nega-
tive selection. Second, experience with defibrillation and using CoreValve (Typevalve=1,
0 for Sapiens) replacement valves on the other hand seems to be positively associated
with patient survival. This positive relationship reflects again either a direct learning or
a selection effect. Positive selection might also be interpreted as a form of learning as
physicians become better at selecting patients with certain characteristics which have a
10The VIF for regressor k is defined as: 1
1−R2k
, where R2k is the R-squared from a regression of xk on
all other explanatory variables
11A porcelain aorta is a heavily calcified ascending thoracic aorta which may obviate usual aortic valve
replacement through that approach.
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higher probability of being alive after two years. Whereas the CoreValve indicator is the
most robust experience variable across all specifications, valve types are constant within
hospitals and might therefore pick up part of the learning differences between hospitals.
One possible explanation for this effect is the practice of clinical proctoring which is more
extensive for Corevalve. In practice this means that Corevalve users receive a longer guid-
ance from an experienced physician. Besides the subgroup experience variables, the Lasso
also identifies the annual TAVI patient volumes (economies of scale) as a key negative
predictor of 2-year survival. In column (2), the Elastic Net singles out more subgroup
experience variables. Nevertheless, the original variables from Lasso are retained and they
practically have the highest effects on 2-year survival12. Finally, the results in column (3)
show the selection of optimal subsets of predictors for a logistic Lasso specification. The
results again provide evidence for a positive subgroup learning effect of using CoreValve
replacement valves. However, the logistic Lasso includes substantially fewer variables
and adds several variables in comparison with the non-logistic Lasso. Whereas without
shrinking, results between logistic and LPM’s are mostly similar, this does not seem to
hold when an L1 penalty is applied. The divergence may be due to different penalties in
the ordinary and logistic lasso combined with the lasso adjustment to the lars algorithm
(when a variable is changing signs, the coefficient is temporarily set to 0).
— Insert Table III here —
4.4 Theil-Goldberger Mixed Estimation
Whereas computation of the Lasso is relatively straightforward, the Theil-Goldberger
(TG) method is not standardly available in statistical software13. Computation requires
12Results from including quadratic terms to capture non-linearities are qualitatively similar to results
in table 3.
13In Stata, the tgmixed command implements a limited version of the Theil-Goldberger mixed estima-
tion method. There is no option to include robust standard errors for the “real” data (which is a priori
essential for a Linear Probability Model) and there is no possibility to insert prior information on the
sum of coefficients. Mata program code is available upon request, the tgmixed command ado file was
used as a guide.
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the calculation of the formulas in equation (4) and (5) (see section 3.2.2 above). Re-
sults of this computation with a stochastic constraint are provided in specifications (3)-
(4) in table IV below next to OLS where specification (1) shows LPM estimates using
heteroscedasticity-robust standard errors and specification (2) shows generalized least
squares (GLS) estimates. For the Theil-Goldberger estimation we implement robust stan-
dard errors (specification (3)) and a GLS form (specification (4)) for the non-augmented
part. The latter refers to the use of weighted least squares on the non-augmented data,
i.e., the matrix Ω−1 is estimated to obtain a feasible GLS estimate.
Overall, the results show that the change from OLS to GLS contributes more in effi-
ciency terms than TG estimation. In contrast, the effect of implementing the stochastic
constraint on coefficients only has a limited impact on standard errors and significance.
However, there are some differences in significance between models (2) and (4). In-
tuitively, the additional information that is added in the TG estimation seems rather
limited. Nevertheless, although there are no qualitative differences between the OLS and
TG specifications without GLS, we clearly observe differences in significance between
the second and fourth specification (see grey shaded bars in table IV below): On top of
experience with aortic aneurysm (“Experience aortic aneurism”), carotis disease (“Expe-
rience carotis disease”), hypertension (“Experience hypertension”), porcelain aorta (“Ex-
perience porcelain aorta”) and transfemoral access (“Experience transfemoral access”),
we find additional significant effects for atrial fibrillation (”Experience atrial fibrillation”)
and New York Heart Association category 3 (“Experience NYHAcat3”) when using TG
mixed estimation.
These findings should be closely scrutinized to find how experience translates in better
outcomes. In particular, we find evidence for positive learning effects on 2-year survival for
treating more patients overall (learning from cumulative experience), as well as treating
more patients with hypertension. On the other hand, treating additional patients with
an aortic aneurism, atrial fibrillation, carotis disease, porcelain aorta or using the trans-
femoral access route is associated with lower patient survival and thus indicating negative
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subgroup learning effects. This evidence for negative subgroup learning strongly suggests
the presence of selection effects. For patients with these characteristics the severity of the
characteristic changes over time such that they are more likely to die in two years’ time.
— Insert Table IV here —
Summing up, the comparison of the the TG mixed estimation with the Lasso results
in Table III provides mixed evidence. While both methods single out subgroup effects as
important factors for survival, there is no agreement on which subgroups are more relevant.
This finding may result from the fact that in the Lasso, some of the variables pick up
effects from others that are truly controlled for in the Theil-Goldberger method or from
the inappropriateness of the summation constraint on the subgroups. As a consequence,
we suggest to compare both Lasso and Theil-Goldberger mixed estimation results and to
interpret them with care. These results should then be further discussed and investigated
by policy makers and practitioners to improve survival.
5 Robustness checks
While we have already assessed the robustness of our findings to different model specifica-
tions and estimation techniques, in this subsection, we check the robustness of our findings
to changes in the sample size. In table V below, we remove the four largest hospitals one
by one from the regressions with 2-year survival as the dependent variable. The results
from these removals are almost perfectly identical to the original regressions shown above
in table I. In particular, we find a positive and significant effect of cumulative experience
on 2-year survival14. As above, there is no evidence for an effect of economies of scale or
human capital depreciation on 24-month survival as essentially none of the coefficients is
statistically significant different from zero.
14Only for hospital 19 the significance disappears. This is however caused by the drop in degrees of
freedom rather than a change in coefficients as can be seen from the regression without hospital 20.
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— Insert Table V here —
For adverse cardiac events displayed in table VI, we find that the significant effect of
human capital depreciation for renal failure disappears when cases that were more than
100 days apart were removed mainly because of a sizeable drop in the coefficient size.
However, the effect reappears if the sample is increased to procedures with less than 150
days time difference (see specification 2). The results for renal failure are therefore mainly
driven by observations for which more than 100 days have passed since the team has
last performed the TAVI procedure indicating that the negative effects of human capital
depreciation only manifest themselves for relatively long time periods between procedures.
Interestingly, the same pattern emerges when analyzing the effects on having a stroke:
The coefficient on human capital depreciation becomes insignificant for observations with
fewer than 100 days difference but turns significant once including all observations with
less than 150 days between procedures. The insignificance can be attributed to a drop
in degrees of freedom because the coefficient increases in size. In line with the results
above, when the sample is restricted, we find a highly significant and positive effect on
the “Zero days since last procedure” indicator in all subsamples pointing towards that
the cardiology team loses concentration during the course of a day and therefore is more
likely to cause medical errors when performing more than one procedure on a given day.
— Insert Table VI here —
Whereas a broad range of results is provided, several concerns remain. First, while in
the Belgian case there is little evidence for a causal relationship from outcome to volume,
it would have been better to explicitly address this issue in the analysis. To remove the
endogeneity bias caused by selective referrals in the overall effect, the literature usually
employs instrumental variable methods. However, we did not have any sensible instru-
ment at our disposal. Because our focus lies on the subgroup analysis, also selection is
informative to obtain knowledge to improve performance. The drawback of our method is
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that we are unable to disentangle true learning from selection effects. Second, assuming
effects to be linear imposes a heavy strain on the analysis. Including squared terms in
the Lasso regressions did not qualitatively influence the results. For the Theil-Goldberger
method, if in fact the overall learning curve would be non-linear, the specific structure
of the experience variables may pick up these non-linearities. Graphical intuition on this
argument is provided in Appendix C. The combination of the Theil-Goldberger mixed
estimation method and logistic models is practically infeasible and therefore this lim-
itation remains. Nevertheless, a linear approach provides a useful first insight in the
decomposition of learning curves.
6 Conclusion
In the last decades, a whole strand of literature has contributed to learning, volume and
scale effects in healthcare provision. In this paper we explore both overall, as well as
subgroup learning curves using information on the first 860 Transcatheter Aorta Valve
Implantations (TAVI) in Belgium. Considering overall learning, we distinguish between
economies of scale, learning from cumulative experience and human capital depreciation
and assess their role for patient survival and adverse cardiac events during the TAVI
procedure. Overall, our analysis shows that different types of learning apply for different
outcomes: while cumulative experience is of great importance for 24-month survival, more
frequent practice plays a key role for adverse events like renal failure and stroke.
In addition, we extend the existing literature by exploring subgroup learning effects
which provides an extra instrument to potentially improve and explain provider perfor-
mance. Knowing that certain groups of patients contribute to the learning process gives
more detailed information for both policy makers and healthcare providers to improve
clinical practice. We apply both Lasso regression as a variable selection method and
Theil-Goldberger mixed estimation to augment the data. Underlying the overall effects of
treating more patients are subgroup learning effects for experience with using CoreValves
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replacement valves, hypertension, aortic aneurysm and physicians experience with defib-
rillators – to name a few. Trying to improve processes of care, these groups or techniques
should be closely investigated by both practitioners and policy makers.
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TABLES
Table I: Overall Learning Effects:
Survival & Major Adverse Cardiac Events (MACE)
Outcome Variable 24-Month Survival MACE Pacemaker MACE Renal Failure MACE Stroke
Specification (1) (2) (3) (1) (2) (3) (1) (2) (3) (1) (2) (3)
Economies of Scale -0.0040** -0.0053** -0.0044 0.0011 0.0018 -0.0018 -0.0009 -0.0004 0.0007 -0.0007 -0.0004 -0.0012
(0.0020) (0.0023) (0.0031) (0.0017) (0.0018) (0.0031) (0.0015) (0.0017) (0.0025) (0.0009) (0.0008) (0.0011)
Cumulative Experience 0.0013* 0.0013* 0.0016** 0.0012* 0.0013* 0.0009 0.0004 0.0004 -0.0001 0.0002 0.0003 0.0002
(0.0006) (0.0007) (0.0008) (0.0007) (0.0007) (0.0008) (0.0005) (0.0006) (0.0007) (0.0003) (0.0003) (0.0004)
Human Capital Depreciation -0.0001 -0.0004 -0.0005 0.0000 0.0002 0.0003 0.0006 0.0009* 0.0012** 0.0002 0.0005 0.0007**
(0.0006) (0.0006) (0.0006) (0.0004) (0.0004) (0.0004) (0.0006) (0.0005) (0.0005) (0.0003) (0.0003) (0.0004)
Zero Days Since Last Procedure -0.0134 -0.0342 -0.0396 0.0591* 0.0394 0.0497 0.0418 0.0482 0.0518 0.0165 0.0315* 0.0403**
(0.0379) (0.0390) (0.0400) (0.0327) (0.0325) (0.0331) (0.0314) (0.0316) (0.0336) (0.0174) (0.0182) (0.0194)
Patient- and procedure-specific characteristics No Yes Yes No Yes Yes No Yes Yes No Yes Yes
Hospital fixed-effects No No Yes No No Yes No No Yes No No Yes
Number of Observations 854 780 780 754 692 691 758 697 696 759 697 696
Notes: Linear probability model estimates of the overall learning curves for 2-year survival and MACE indicators for pacemaker implantation, renal failure and stroke using three different model specifications: Model 1 includes no
covariates; Model 2 then adds controls for several patient- and procedure-specific characteristics; Model 3 adds hospital fixed-effects. Heteroscedasticity-robust standard errors in parentheses. *** p < 0.01 ** p < 0.05 * p < 0.1.
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Table II: Subgroup Learning Effects:
LPM Estimates and Variane Inflation Factors
Outcome Variable: 24-Month Survival Coefficient VIF
Economies of Scale -0.0084* 8.263
(0.0047)
Cumulative Experience 0.0388 9138.332
(0.0488)
Human Capital Depreciation -0.0005 1.729
(0.0006)
Zero Days Since Last Procedure -0.0427 1.586
(0.0399)
Experience female -0.0179 277.921
(0.0172)
Experience angina -0.0062 186.697
(0.0181)
Experience aortic aneurism -0.0750* 81.684
(0.0398)
Experience artial fibrillation -0.0197 172.285
(0.0224)
Experience carotis disease -0.0155 62.654
(0.0182)
Experience coronary artery disease 0.0085 649.885
(0.0217)
Experience coronary obstructive disease -0.0127 96.161
(0.0185)
Experience chronic heart failure -0.0053 378.212
(0.0116)
Experience diabetes 0.0050 123.441
(0.0234)
Experience hypertension 0.0241 549.234
(0.0156)
Patient- and procedure specific characteristics Yes
Hospital fixed-effects Yes
Number of Observations 780
Notes: For the sake of brevity, the table shows only a selection of the coefficients on
the experience variables. Heteroscedasticity-robust standard errors in parentheses:
*** p < 0.01 ** p < 0.05 * p < 0.1.
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Table III: Subgroup Learning:
Variable Selection Methods
Outcome Variable: 24-Month Survival
Specification (1) (2) (3)
OLS on Lasso OLS on Elastic Net Logistic Lasso
Economies of Scale -0.004* -0.005** -0.012
Human Capital Depreciation - -0.020 0.0002
Female 0.028 0.030 -
Atrial fibrillation -0.054 -0.052 -
Carotis disease 0.113*** 0.115*** -
Chronic obstructive pulmonary disease -0.115*** -0.113*** -
Pulmonary hypertension -0.069** -0.077** -
Porcelain aorta -0.107* -0.094 -
Renal failure -0.074* -0.080** -
PCI - -0.026 -
Stroke -0.101** -0.099** -
NYHAcat2 - 0.016 -
NYHAcat4 -0.038 -0.052 -
CoreValve 0.035 0.042 -
Transfemoral access 0.109*** 0.103** -
Medium valve -0.112** -0.096** -
exp pulmonary hypertension - 0.003 -
exp porcelain aorta -0.006 -0.006 -
exp renal failure - 0.008* -
exp medrad - -0.004 -
exp defibrillator 0.074* 0.039 -
exp CoreValve 0.002* 0.007 0.006
exp chronic heart failure - - -0.006
exp small valve - -0.008 0.015
exp highef - -0.005
Hospital Fixed Effects No No No
Observations 780 780 780
Notes: Columns (1) and (2) show the OLS coefficient estimates on the Lasso and Elastic Net selection of optimal predictors for
2-year survival. Column (3) displays the Logistic Lasso selection of predictors: *** p < 0.01 ** p < 0.05 * p < 0.1.
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Table IV: Subgroup Learning:
Theil-Goldberger Mixed Estimation
Outcome Variable: 2-Year Survival OLS Theil-Goldberger
Robust GLS Robust GLS
(1) (2) (3) (4)
Coef. S.E. Coef. S.E. Coef. S.E. Coef. S.E.
Economies of Scale -0.008* 0.005 -0.004 0.003 -0.008* 0.005 -0.004 0.003
Cumulative Experience 0.039 0.049 0.071* 0.040 0.050 0.047 0.086** 0.036
Human Capital Depreciation -0.001 0.001 0.000 0.001 -0.001 0.001 0.000 0.000
Zero Days Since Last Procedure -0.043 0.040 -0.013 0.035 -0.043 0.040 -0.015 0.033
Exper female -0.018 0.017 -0.017 0.015 -0.019 0.017 -0.019 0.014
Exper angina -0.006 0.018 -0.006 0.016 -0.003 0.018 -0.002 0.015
Exper aortic aneurism -0.075* 0.040 -0.085** 0.034 -0.067* 0.039 -0.073** 0.030
Exper atrial fibrillation -0.020 0.022 -0.028 0.020 -0.027 0.021 -0.038** 0.017
Exper carotis disease -0.015 0.018 -0.029* 0.016 -0.017 0.018 -0.030* 0.015
Exper coronary artery disease 0.008 0.022 0.025 0.018 0.008 0.022 0.023 0.017
Exper chronic obstructive pulmonary disease -0.013 0.019 -0.014 0.016 -0.015 0.018 -0.015 0.015
Exper chronic heart failure -0.005 0.012 0.001 0.010 -0.004 0.011 0.003 0.010
Exper diabetes 0.005 0.023 0.013 0.020 0.007 0.023 0.016 0.018
Exper hypertension 0.024 0.016 0.024* 0.014 0.021 0.015 0.022* 0.013
Exper pulmonary hypertension 0.004 0.011 0.000 0.009 0.006 0.010 0.002 0.008
Exper myocardial infarction -0.011 0.019 -0.013 0.016 -0.012 0.019 -0.013 0.015
Exper porcelain aorta -0.013 0.026 -0.038* 0.021 -0.010 0.026 -0.034* 0.020
Exper renal failure 0.011 0.017 -0.003 0.015 0.008 0.017 -0.006 0.014
Exper pci -0.006 0.020 -0.017 0.018 -0.008 0.020 -0.020 0.017
Exper pacemaker -0.008 0.022 0.011 0.018 -0.012 0.022 0.005 0.017
Exper stroke 0.036 0.027 0.010 0.024 0.035 0.027 0.008 0.022
Exper nyhacat2 -0.028 0.039 -0.029 0.031 -0.036 0.038 -0.040 0.028
Exper nyhacat3 -0.031 0.033 -0.031 0.026 -0.039 0.032 -0.042* 0.023
Exper nyhacat4 -0.005 0.039 -0.011 0.030 -0.012 0.038 -0.020 0.028
Exper mediastinal radiation -0.006 0.047 -0.002 0.040 -0.007 0.047 -0.004 0.037
Exper defibriallator -0.126 0.118 -0.038 0.088 -0.112 0.117 -0.026 0.082
Exper CABG 0.010 0.026 -0.012 0.021 0.013 0.026 -0.006 0.020
Exper valve surgery 0.043 0.054 0.050 0.051 0.056 0.052 0.067 0.046
Exper CoreValve 0.019 0.020 0.016 0.016 0.019 0.020 0.019 0.015
Exper transfemoral access -0.026 0.017 -0.042*** 0.014 -0.027 0.017 -0.044*** 0.013
Patient- and procedure-specific characteristics Yes Yes Yes Yes
Hospital fixed-effects Yes Yes Yes Yes
Number of Observations 780 780 780 780
Notes: OLS and Theil-Goldberger Mixed Estimation estimates of the overall and subgroup learning curves. For the sake of brevity, the coefficient
estimates on the patient- and procedure-specific characteristics and the hospital indicators are not shown in the table above. Heteroscedasticity-
robust standard errors in parentheses: *** p < 0.01 ** p < 0.05 * p < 0.1.
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Table V: Robustness Checks:
Exclusion of the Largest Hospitals
Outcome Variable: 24-Month Survival
Excluding Hospital 12 Hospital 17 Hospital 19 Hospital 20
Economies of Scale -0.0063* -0.0047 -0.0033 -0.0048
(0.0033) (0.0032) (0.0033) (0.0036)
Cumulative Experience 0.0020** 0.0019** 0.0016 0.0016*
(0.0008) (0.0008) (0.0010) (0.0009)
Human Capital Depreciation -0.0003 -0.0002 -0.0007 -0.0005
(0.0007) (0.0007) (0.0007) (0.0007)
Zero Days Since Last Procedure -0.0271 -0.0134 -0.0556 -0.0448
(0.0422) (0.0422) (0.0441) (0.0434)
Patient- and Procedure-specific characteristics Yes Yes Yes Yes
Hospital fixed-effects Yes Yes Yes Yes
Number of Observations 708 707 659 680
Notes: For the sake of brevity, the coefficient estimates on the patient- and procedure-specific characteristics and the hospital indicators
are not shown in the table above. Heteroscedasticity-robust standard errors in parentheses: *** p < 0.01 ** p < 0.05 * p < 0.1.
32
Table VI: Robustness Checks:
Varying Time Since Last Procedure
Outcome Variable MACE Renal Failure MACE Stroke
Overall Timediff < 150 Timediff < 100 Overall Timediff < 150 Timediff < 100
Specification (1) (2) (3) (1) (2) (3)
Economies of Scale 0.0007 0.0005 0.0008 -0.0012 -0.0012 -0.0015
(0.0025) (0.0025) (0.0025) (0.0011) (0.0011) (0.0011)
Cumulative Learning -0.0001 -0.0001 -0.0001 0.0002 0.0002 0.0003
(0.0007) (0.0007) (0.0007) (0.0004) (0.0004) (0.0004)
Human Capital Depreciation 0.0012** 0.0012* 0.0009 0.0007** 0.0012** 0.0008
(0.0005) (0.0007) (0.0008) (0.0004) (0.0006) (0.0005)
Zero Days Since Last Procedure 0.0518 0.0492 0.0460 0.0403** 0.0545** 0.0430**
(0.0336) (0.0344) (0.0359) (0.0194) (0.0224) (0.0218)
Patient- and Procedure-specific characteristics Yes Yes Yes Yes Yes Yes
Hospital fixed-effects Yes Yes Yes Yes Yes Yes
Number of Observations 696 688 677 696 688 677
Notes: For the sake of brevity, the coefficient estimates on the patient- and procedure-specific characteristics and the hospital indicators are not shown in the table above. Heteroscedasticity robust
standard errors in parentheses: *** p < 0.01 ** p < 0.05 * p < 0.1.
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Appendix A: Descriptive Statistics
Table VII: Summary Statistics
Mean S.D. Min Max N
24-Month Survival Rate 0.71 0.45 0 1 780
Annual Volume 18.66 9.85 1 37 780
Time Since Last Procedure (Days) 21.4 32.82 0 339 780
Age 82.55 6.10 50 98 780
Female 0.53 0.5 0 1 780
Angina 0.29 0.45 0 1 780
Aortic Aneurism 0.05 0.22 0 1 780
Atrial Fibrillation 0.3 0.46 0 1 780
Carotid Artery Disease 0.2 0.4 0 1 780
Coronary Artery Disease 0.61 0.49 0 1 780
Chronic Obstructive pulmonary disease 0.29 0.45 0 1 780
Chronic Heart Failure 0.68 0.47 0 1 780
Diabetes 0.25 0.43 0 1 780
Hypertension 0.76 0.43 0 1 780
Pulmonary Hypertension 0.55 0.5 0 1 780
Heart Attack 0.22 0.42 0 1 780
Porcelain Aorta 0.08 0.27 0 1 780
Renal Failure 0.25 0.43 0 1 780
Pacemaker 0.13 0.34 0 1 780
Stroke 0.16 0.37 0 1 780
NYHA cat2 0.18 0.39 0 1 780
NYHA cat3 0.6 0.49 0 1 780
NYHA cat4 0.2 0.4 0 1 780
Mediastinal Radiation 0.05 0.21 0 1 780
Defibrillator 0 0.06 0 1 780
CABG 0.26 0.44 0 1 780
Valve Surgery 0.03 0.16 0 1 780
CoreValve 0.45 0.5 0 1 780
Transfemoral Access 0.76 0.43 0 1 780
Notes: Summary statistics for the full set of outcome variables and all patient- and
procedure specific characteristics.
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Appendix B: Economies of Scale


































Appendix C: Days Since Last Procedure
The number of days since last performing TAVI ranges from a minimum of zero days to a
maximum of 408 days with a mean value of roughly 26 days (median 14 days) in between
procedures. The distribution of the temporal distance to the last TAVI procedure in the
overall sample is shown in Figure 4 below.










0 100 200 300 400
Time Since Last Procedure (Days)
Days Since Last TAVI
Notes: The Figure shows the distribution of the days since the last TAVI procedure and is
overlaid with a kernel density estimate (solid dark blue line).
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Appendix D: Visual Intuition on Non-linear Effects
The first plot below is an added variable plot showing the curvature in the effect of
patient number on 2-year mortality. The added variable plot displays two clouds of
observations. The clustering of observations in these two clouds signals a poor fit which
results from the use of linear probability models. However, the use of LPM’s instead
of more sophisticated models is warranted because of the assumption of linear effects
in determining the constraint. The matrix of graphs shows the relationship between
patient number and the significant experience variables identified by the Theil-Goldberger
estimation. If in reality the effect of patient number (or cumulative learning) would be
non-linear, it might be that the other experience variables become significant depending
on their relationship to the patient number. If the pattern of this relationship exhibits the
same pattern as the first figure, the other experience variables may pick up the underlying
non-linearity of the patient number. Visually we are not able to detect strong similarities
between the graphs suggesting that signicant results in Theil-Goldberger are not fully
driven by non-linearities in the patient number.
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